Sirona Biochem (TSE:SBM) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Sirona Biochem has announced a study showcasing the efficacy of their TFC-1326 compound in reducing signs of skin aging, published in the Journal of Cosmetic Dermatology. The research highlights improvements in skin elasticity, firmness, and reduction of wrinkles, positioning the compound as a promising anti-aging solution. This publication marks a significant milestone for the company, opening doors for future commercial opportunities.
For further insights into TSE:SBM stock, check out TipRanks’ Stock Analysis page.